Schonfeld Strategic Advisors 13F: Cuts AMETEK (AME) Stake by $28M

In its latest Form 13F filing with the SEC, Schonfeld Strategic Advisors revealed a sharp reduction in its stake in industrial technology company AMETEK, Inc. (NYSE:AME). The investment firm cut its position in the company by 66.99% during the quarter ending May 15, 2026. Schonfeld parted with 116,248 shares, leaving it with 57,290 shares valued at approximately $13.92 million at the end of the reporting period.

Schonfeld Trims AMETEK Position

The sell-off scaled back Schonfeld's holdings from its previous level of 173,538 shares. The remaining block of 57,290 shares represented a significant pullback for the firm, which had a cost basis of $167.18 per share on its investment. Because 13F filings are backward-looking, this snapshot reflects Schonfeld's portfolio as of the middle of May and might not represent its current holdings in the Pennsylvania-based manufacturer.

Diverging Institutional Moves in AMETEK

Schonfeld's decision to trim its holdings contrasts with several other major institutional players that decided to build up their stakes in AMETEK around the same time. For instance, Dz Bank AG dramatically expanded its position by 586%, bringing its total ownership to nearly 1.3 million shares. Citigroup also grew its holdings by 45%, ending the period with 187,180 shares valued at roughly $45.48 million. Other buyers included BNP Paribas Asset Management Holding S.A., which boosted its stake by 4.9%, and Raymond James Financial, which raised its holdings by 1.4%. Lpl Financial also joined the buyers, adding over 32,000 shares. On the other hand, Wealth Enhancement Advisory Services took a path similar to Schonfeld, slashing its AMETEK holdings by 64.5% after selling 87,776 shares.

AMETEK Stock Hovers Near Moving Averages

Shares of AMETEK closed at $242.99 on Saturday, trading comfortably above their 200-day moving average of $228.07 and just slightly ahead of the 50-day moving average of $241.51. The stock has traded within a 52-week range of $179.24 to $261.16. With a price-to-earnings ratio of 35.27 and a forward P/E of 25.17, the stock's valuation reflects steady investor confidence, supported by a beta of 0.99 that suggests it moves in close alignment with the broader market.

Recent Earnings

AMETEK's underlying financial health remains solid, supported by its most recent financial reports. The company generated $7.86 billion in revenue, representing a 15.0% growth rate. Profitability metrics are also strong, with a net margin of 20.04% and a return on equity of 14.56%. The company posted earnings of $6.84 per share. Shareholders are looking ahead to October 29, 2026, when the firm is scheduled to release its next quarterly earnings report.

Dividend

For income-focused investors, AMETEK offers an annual dividend of $1.36 per share, which translates to a dividend yield of 0.57%. The company maintains a conservative dividend payout ratio of 19.01%, indicating that it retains the vast majority of its profits to reinvest back into the business or fund future acquisitions rather than returning them immediately to shareholders.

Analysts Set New Price Targets

Wall Street analysts maintain a generally positive view of AMETEK, with a consensus "buy" recommendation from the 18 analysts tracking the stock. The average 12-month price target stands at $278.33, with estimates ranging from a low of $217.00 to a high of $316.00. Several firms adjusted their expectations in late 2026. On September 11, 2026, BNP Paribas maintained its Outperform rating with a $290.00 price target. On October 5, 2026, Baird kept a Neutral rating while setting a $280.00 target. More recently, on October 12, 2026, Citigroup maintained its Neutral rating and adjusted its price target to $263.00. Other firms like Truist Securities and TD Cowen also hold Buy ratings with targets of $316.00 and $275.00, respectively.

Inside AMETEK's Industrial Business

AMETEK designs and builds advanced electronic instruments and electromechanical devices. The company serves a wide variety of industries, including aerospace, defense, medical technology, and oil and gas, by making everything from aircraft sensors to surgical tools. This diverse industrial footprint helps buffer the firm against localized economic downturns.

Tracking AMETEK's Next Steps

Investors will want to keep a close eye on AMETEK's upcoming earnings release on October 29, 2026, to see if the company can maintain its double-digit revenue growth. Additionally, future 13F filings will reveal whether Schonfeld continues to exit its position or if other institutional giants resume buying shares. As always, these regulatory filings are delayed by design, so current portfolio allocations may have shifted since the mid-May reporting date.